AllenCHoMDFACS
Ophthalmology • Philadelphia, PARetinal Disease
Director of Retina Research Wills Eye Hospital Professor of Ophthalmology, Jefferson Medical College
Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 Walnut St
Fl 10
Philadelphia, PA 19107Phone+1 800-331-6634Fax+1 215-825-2443
Summary
- Dr. Allen Ho is an ophthalmologist based in Philadelphia, PA, specializing in retinal disease. He completed his education at Columbia University and trained in ophthalmology at Thomas Jefferson University/Wills Eye Hospital. Dr. Ho is the Director of Retina Research at Wills Eye Hospital and holds academic positions at Thomas Jefferson University. His expertise includes translational clinical trials, cell and gene therapies, surgical retinal disease, diabetes mellitus, diabetic retinopathy, and macular degeneration. He has contributed numerous publications to prominent ophthalmology journals. He has participated in several clinical trials related to retinal health. Dr. Ho has been recognized as one of the most influential ophthalmologists and consistently listed as a top doctor by various organizations.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1989 - 1992
Atlantic Health System/Morristown Medical CenterInternship, Internal Medicine, 1988 - 1989
Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
PA State Medical License 1990 - 2026
NJ State Medical License 1997 - 2025
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- 100 Most Influential Ophthalmologists in the World The Ophthalmologist, 2019-2023
- Top Docs of Philadelphia Philadelphia Magazine, 2008-2023
- Philadelphia Magazine Castle Connolly, 2008-2023
- Join now to see all
Clinical Trials
- Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion Start of enrollment: 2011 Sep 01
- New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System Start of enrollment: 2014 Jan 01
- Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment. Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- OUTCOMES IN EYES WITH RETAINED LENS FRAGMENTS UNDERGOING PARS PLANA LENSECTOMY AND SCLERAL-FIXATED INTRAOCULAR LENS INSERTION.Asad F Durrani, Bita Momenaei, Jonathan L Martin, Taku Wakabayashi, Saif A Hamdan
Retina. 2025-02-01 - Retinal Tear and Retinal Detachment after Cataract Surgery in Eyes with a Previous History of Treated Phakic Retinal Tears.Bita Momenaei, Andrew Zhou, Adina S Kazan, Taku Wakabayashi, Anthony Obeid
Ophthalmology. 2024-12-01 - Functional Outcomes and Quality of Life in Geographic Atrophy in the Clinical Setting.Durga Borkar, Ehsan Rahimy, Mohammed Ali Khan, Allen C Ho, Meghan Hatfield
Ophthalmology. Retina. 2024-11-20
Press Mentions
Geographic Atrophy Therapies to WatchDecember 14th, 2024- Evidence of Durable Vision Improvement with Gene Therapy for Retinitis PigmentosaOctober 22nd, 2024
- New Gene Therapy for Retinitis Pigmentosa Shows PromiseOctober 20th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Retina SocietyExecutive Board
- Macula SocietyMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
